(VIANEWS) – Shares of 10x Genomics (NASDAQ Composite: TXG) slid by a staggering 11.78% to $104.82 at 03:32 EST on Friday, after five successive sessions in a row of losses. NASDAQ Composite is rising 0.05% to $14,942.83, following the last session’s downward trend. This seems, at the moment, a somewhat positive trend trading session today.
10x Genomics’s last close was $104.82, 49.84% below its 52-week high of $208.99.
Today’s last reported volume for 10x Genomics is 2397388 which is 239.44% above its average volume of 706269.
10x Genomics’s Sales
10x Genomics’s sales growth is 78.1% for the current quarter and 33.2% for the next. The company’s growth estimates for the present quarter and the next is 70.8% and 97.2%, respectively.
10x Genomics’s Revenue
Year-on-year quarterly revenue growth grew by 170%, now sitting on 405.7M for the twelve trailing months.
10x Genomics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.48%, a negative 0.84%, and a positive 2.83%, respectively.
10x Genomics’s highest amplitude of average volatility was 2.48% (last week), 2.39% (last month), and 2.83% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
10x Genomics’s stock is considered to be overbought (>=80).
10x Genomics’s Stock Yearly Top and Bottom Value
10x Genomics’s stock is valued at $104.82 at 03:32 EST, way under its 52-week low of $128.15.
10x Genomics’s Moving Average
10x Genomics’s value is way below its 50-day moving average of $155.93 and way under its 200-day moving average of $170.12.
More news about 10x Genomics (TXG).